Displaying 1–25 of 71 results for Unit Operations
More details are emerging about the months leading up to Novartis’s admission that data results for its gene therapy Zolgensma were manipulated.
According to the Japanese company the acquisition is meant to shore up its healthcare business.
AstraZeneca will be closing two manufacturing sites in Colorado in order to consolidate its biologics manufacturing network in one large-scale drug substance facility.
Dr Reddy's Laboratories announced that it has entered into a definitive agreement for the sale of its active pharmaceutical ingredients manufacturing business unit located in Jeedimetla, Hyderabad, to Therapiva Private Limited.
Pfizer announced its executive team that will report to Albert Bourla, incoming CEO. Bourla begins his time in the role next year on January 1.
Bayer is planning to overhaul its R&D operations and considering new plans that could include job cuts and outsourcing.
Aspen Pharmacare has announced plans to open a new $80 million plant.
Novartis’ operations president, Andre Wyss, is leaving the company, where he was responsible for streamlining production and corporate services.
Merck Operating Unfair Discount Scheme Says UK Watchdog. Provisionally, the Competition and Markets Authority found that Merck's European unit had abused its market position, opening up the drugmaker to financial penalties.
Sun Pharma said the U.S. FDA will lift the ban on Sun's Mohali plant in Punjab, India, allowing the company to resume export operations after four years
The Facility of the Year Awards recognize state-of-the-art projects using new technologies to improve product quality, reduce the cost of producing high-quality medicines and demonstrate advances in project delivery
The acquisition will allow MICRODYN-NADIR to be a one-stop shop with a wide range of membrane filtration products
Although considering a split into two companies for more than two years, the company said it would not create any shareholder value
Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions, today announced that it is expanding its micro-dosing services offering for early-phase feasibility work.
Six companies recognized for innovative pharma/biopharma technologies
The European Union announced on Thursday that it had given the okay for Teva Pharmaceuticals’ $40.5 billion deal to buy Allergan's generic drug business, provided the companies sell some operations in Europe to ease antitrust concerns.
Pfizer will manage its commercial operations through two distinct businesses: the innovative products business and established products business
In addition to the 600 layoffs, 296 R&D positions that were to be filled in France will be eliminated
Baxter International announced it has named José (Joe) Almeida the company's Chairman and CEO, effective January 1, 2016.
The new plant will be focused on filling and packaging of protein therapeutics
Ramona Sequeira will join TPUSA as president of the U.S. Business Unit
David Mayers has been appointed president of WellSpring Pharma Services
Japanese health authorities plan to order a 15-day suspension for the Novartis unit in Japan for failing to report side effects associated with its drugs.
Inspectors noted "significant violations of current good manufacturing practice (CGMP) regulations" for finished pharmaceuticals